Funding for this research was provided by:
shanghai hospital development centre (SHDC2020CR1024B)
Received: 3 August 2021
Accepted: 25 August 2021
First Online: 8 September 2021
: The independent ethics committee (IEC) of Changzheng Hospital approved the study protocol (Protocol code: CZ1812ACAF, Version 1.0, Issue date: 2021-06-21) for all of the currently planned participating centres (Approval No. 2021SL029). The IEC agreed that this study will not raise patients’ risk or cause extra harm to patients. The IEC further agreed that the study is in accordance with the Declaration of Helsinki. All subjects will be required to sign a written informed consent document before their participation in the study. The study had purchased medical insurance for any compensation to those who suffer harm from trial participation.
: Not Applicable.